The Ensign Group, Inc.
ENSG Healthcare Medical Care Facilities
The Ensign Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 18.7% from fiscal 2024.
- Revenue
- +14.5%
- EPS
- +23.6%
- Free cash flow
- +89.2%
- Total debt
- +39.2%
Quarter to September 2026, against a year earlier
Follow ENSG
Alert me
The Ensign Group, Inc. (ENSG) P/B ratio
As of 5 November 2026, The Ensign Group, Inc. (ENSG) trades at a P/B ratio of 4.1×. Over the past ten years it has ranged from 1.8× (February 2017) to 6.3× (March 2021); the current reading is higher than 62% of that period. That is above the Medical Care Facilities industry median of 3.1× and above the Healthcare sector median of 2.3×.
P/B ratio, daily
Embed this chart
Annual newest first
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 4.5× | 9.22% |
| FY2024 | 4.1× | (4.12%) |
| FY2023 | 4.3× | 2.69% |
| FY2022 | 4.2× | (7.23%) |
| FY2021 | 4.5× | (5.98%) |
| FY2020 | 4.8× | 28.84% |
| FY2019 | 3.7× | 18.95% |
| FY2018 | 3.1× | 41.10% |
| FY2017 | 2.2× | (3.38%) |
| FY2016 | 2.3× | (8.64%) |
Quarterly newest first
| Period | P/B ratio | Change |
|---|---|---|
| Sep 2026 | 3.9× | 2.12% |
| Jun 2026 | 3.8× | (22.66%) |
| Mar 2026 | 4.9× | 9.97% |
| Dec 2025 | 4.5× | (4.35%) |
| 43 more quarters | Free account |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| DVA DaVita Inc. compare | n/m |
| FMS Fresenius Medical Care AG & Co. KGaA compare | 0.8× |
| LFST LifeStance Health Group, Inc. compare | 3.4× |
| EHC Encompass Health Corporation compare | 4.0× |
| ENSG The Ensign Group, Inc. | 4.1× |
| PACS PACS Group, Inc. compare | 6.5× |
| CHE Chemed Corporation compare | 8.1× |
| CON Concentra Group Holdings Parent, Inc. compare | 10.2× |
| UHS Universal Health Services, Inc. compare | 164× |
| Medical Care Facilities industry median | 3.1× |
| Healthcare sector median | 2.3× |
| Market median | 1.7× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on ENSG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement